Published in Community Ment Health J on October 01, 2000
Managing addiction as a chronic condition. Addict Sci Clin Pract (2007) 3.17
Recovery capital as prospective predictor of sustained recovery, life satisfaction, and stress among former poly-substance users. Subst Use Misuse (2008) 1.73
An examination of main and interactive effects of substance abuse recovery housing on multiple indicators of adjustment. Addiction (2007) 1.60
The Role of Social Supports, Spirituality, Religiousness, Life Meaning and Affiliation with 12-Step Fellowships in Quality of Life Satisfaction Among Individuals in Recovery from Alcohol and Drug Problems. Alcohol Treat Q (2006) 1.56
Adherence to medication regimens and participation in dual-focus self-help groups. Psychiatr Serv (2002) 1.32
Disappearing acts: the social networks of formerly homeless individuals with co-occurring disorders. Soc Sci Med (2007) 1.32
Social support mediates the effects of dual-focus mutual aid groups on abstinence from substance use. Am J Community Psychol (2004) 1.28
The road to recovery: where are we going and how do we get there? Empirically driven conclusions and future directions for service development and research. Subst Use Misuse (2008) 1.28
Pathways to long-term recovery: a preliminary investigation. J Psychoactive Drugs (2002) 1.15
The impact of alcoholics anonymous on other substance abuse-related twelve-step programs. Recent Dev Alcohol (2008) 1.08
A longitudinal analysis of psychiatric severity upon outcomes among substance abusers residing in self-help settings. Am J Community Psychol (2008) 1.06
Effectiveness of dual focus mutual aid for co-occurring substance use and mental health disorders: a review and synthesis of the "Double Trouble" in Recovery evaluation. Subst Use Misuse (2008) 1.04
Perceived reasons for substance misuse among persons with a psychiatric disorder. Am J Orthopsychiatry (2004) 1.03
The effect of 12-step based fellowship participation on abstinence among dually diagnosed persons: a two-year longitudinal study. J Psychoactive Drugs (2004) 1.03
OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users. Soc Sci Med (2012) 1.00
Predictors of retention in dual-focus self-help groups. Community Ment Health J (2003) 0.97
Using information technology to evaluate the detection of co-occurring substance use disorders amongst patients in a state mental health system: implications for co-occurring disorder state initiatives. Community Ment Health J (2007) 0.93
Mediators of effectiveness in dual-focus self-help groups. Am J Drug Alcohol Abuse (2003) 0.91
Factors associated with medication adherence among psychiatric outpatients at substance abuse risk. Open Addict J (2011) 0.91
Social networks of people with dual diagnosis: the quantity and quality of relationships at different stages of substance use treatment. Community Ment Health J (2004) 0.89
12-step participation among dually-diagnosed individuals: a review of individual and contextual factors. Clin Psychol Rev (2008) 0.85
Policy on reintegration of women with histories of substance abuse: a mixed methods study of predictors of relapse and facilitators of recovery. Subst Abuse Treat Prev Policy (2007) 0.84
Specialized 12-step programs and 12-step facilitation for the dually diagnosed. Community Ment Health J (2005) 0.83
Impact of Dual Disorders, Trauma, and Social Support on Quality of Life Among Women in Treatment for Substance Dependence. J Dual Diagn (2012) 0.82
Intra-group Stigma: Examining Peer Relationships Among Women in Recovery for Addictions. Drugs (Abingdon Engl) (2015) 0.76
Risk factors for medication non-adherence among psychiatric patients with substance misuse histories. Ment Health Subst Use (2014) 0.75
Social Support and Treatment Outcome in Alcohol Dependence Syndrome in Armed Forces. J Clin Diagn Res (2015) 0.75
Predictors of alcohol and drug dependence. Can J Psychiatry (2014) 0.75
Usefulness of Gamma Glutamyl Transferase as Reliable Biological Marker in Objective Corroboration of Relapse in Alcohol Dependent Patients. J Clin Diagn Res (2015) 0.75
Comorbid mental health and substance abuse issues among individuals in recovery homes: Prospective environmental mediators. Ment Health Subst Use (2014) 0.75
'We are always in some form of contact': friendships among homeless drug and alcohol users living in hostels. Health Soc Care Community (2015) 0.75
Stigma and Family Relationships of Middle-Aged Gay Men in Recovery. J Gay Lesbian Soc Serv (2016) 0.75
Response: the marriage of drug abuse treatment and 12-step strategies. Sci Pract Perspect (2003) 0.75
When information is insufficient: inspiring patients for medication adherence and the role of social support networking. Am Health Drug Benefits (2011) 0.75
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA (1990) 17.70
Presidential Address-1976. Social support as a moderator of life stress. Psychosom Med (1976) 7.68
Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull (1993) 7.03
A randomized trial of treatment options for alcohol-abusing workers. N Engl J Med (1991) 6.94
How AA works and why it's important for clinicians to understand. J Subst Abuse Treat (1994) 4.23
Social support and smoking cessation and maintenance. J Consult Clin Psychol (1986) 2.92
Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry (1995) 2.73
Outcome of cognitive-behavioral and support group brief therapies for depressed, HIV-infected persons. Am J Psychiatry (1993) 1.76
A comparative evaluation of substance abuse treatment: I. Treatment orientation, amount of care, and 1-year outcomes. Alcohol Clin Exp Res (1999) 1.42
Life stressors, social resources, and late-life problem drinking. Psychol Aging (1990) 1.39
DOUBLE TROUBLE IN RECOVERY: SELF-HELP FOR PEOPLE WITH DUAL DIAGNOSES. Psychiatr Rehabil J (1998) 1.28
A comparative evaluation of substance abuse treatment: V. Substance abuse treatment can enhance the effectiveness of self-help groups. Alcohol Clin Exp Res (1999) 1.27
Recovery challenges among dually diagnosed individuals. J Subst Abuse Treat (2000) 1.24
Zealous self-help groups as adjuncts to psychiatric treatment: a study of Recovery, Inc. Am J Psychiatry (1988) 1.23
The role of self-help programs in the rehabilitation of persons with severe mental illness and substance use disorders. Community Ment Health J (1996) 1.23
Validity of substance use self-reports in dually diagnosed outpatients. Am J Psychiatry (1998) 1.18
Methodological issues in social support and social network research. Soc Sci Med (1988) 1.16
Social networks and recovery: one year after inpatient treatment. J Subst Abuse Treat (1991) 1.15
Social networks and mental health: on overview. Am J Psychiatry (1982) 1.14
Short-term treatment careers and outcomes of previously untreated alcoholics. J Stud Alcohol (1995) 1.06
Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatr Serv (1996) 1.02
The social networks of drug abusers before and after treatment. Int J Addict (1987) 1.01
Outcomes of the treatment climate in psychiatric and substance abuse programs. J Clin Psychol (1998) 0.99
Medical student and patient attitudes toward religion and spirituality in the recovery process. Am J Drug Alcohol Abuse (1996) 0.95
Alcoholics anonymous after treatment: attendance and abstinence. Int J Addict (1983) 0.92
Predicting the short-term outcome of first episodes and recurrences of clinical depression: a prospective study of life events, difficulties, and social support networks. J Clin Psychiatry (1997) 0.92
Social network transactions of psychiatric patients. Soc Sci Med (1992) 0.90
Spirituality and the treatment of the dually diagnosed: an investigation of patient and staff attitudes. J Addict Dis (1996) 0.87
The role of social support in the functioning of patients with unipolar depression. Am J Psychiatry (1983) 0.84
Social networks of residents in supportive housing. Community Ment Health J (1992) 0.84
Narcotics anonymous: its history, structure, and approach. Int J Addict (1985) 0.83
Factors predicting psychosocial recovery in psychiatric patients. Acta Psychiatr Scand (1996) 0.83
ATP-dependent reduction of azide and HCN by N2-fixing enzymes of Azotobacter vinelandii and Clostridium pasteurianum. Biochim Biophys Acta (1967) 5.81
Transcriptional induction of two genes in human cells by beta interferon. Proc Natl Acad Sci U S A (1984) 4.84
Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci U S A (1987) 4.61
Characterization of a new low molecular weight RNA in HeLa cell ribosomes. J Mol Biol (1968) 4.44
Reduction of N2O by biological N2-fixing systems. Biochem Biophys Res Commun (1966) 3.66
Human fibroblast interferon: amino acid analysis and amino terminal amino acid sequence. Science (1980) 2.77
Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A (1996) 2.45
Interferon: purification and initial characterization from human diploid cells. Proc Natl Acad Sci U S A (1976) 2.45
Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence. J Biol Chem (1986) 2.37
Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. Proc Natl Acad Sci U S A (1985) 2.24
Fibroblast interferon induces synthesis of four proteins in human fibroblast cells. Proc Natl Acad Sci U S A (1979) 2.01
Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J (2000) 2.01
In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol (1996) 1.98
Distribution of 5 s RNA in HeLa cells. J Mol Biol (1967) 1.78
An energy-dependent hydrogen-evolution from dithionite in nitrogen-fixing extracts of Clostridium pasteurianum. Biochem Biophys Res Commun (1965) 1.77
Interferon-induced proteins. Purification and characterization of a 15,000-dalton protein from human and bovine cells induced by interferon. J Biol Chem (1984) 1.74
Selective reduction of c-myc mRNA in Daudi cells by human beta interferon. Proc Natl Acad Sci U S A (1984) 1.65
Heterogeneity of purified mouse interferons. J Biol Chem (1975) 1.61
A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol (1991) 1.47
A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. Anal Biochem (1997) 1.47
Ambivalence toward methadone treatment among intravenous drug users. J Psychoactive Drugs (1991) 1.41
Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J Neurosci (1998) 1.34
Polysubstance use among alcoholics. J Addict Dis (2001) 1.32
Clumsiness in children--do they grow out of it? A 10-year follow-up study. Dev Med Child Neurol (1991) 1.29
Recovery challenges among dually diagnosed individuals. J Subst Abuse Treat (2000) 1.24
Isolation and characteristics of flavodoxin from nitrogen-fixing Clostridium pasteurianum. J Biol Chem (1966) 1.23
Consumers as peer specialists on intensive case management teams: impact on client outcomes. Psychiatr Serv (1995) 1.22
Parental substance abuse as a predictor of child maltreatment re-reports. Child Abuse Negl (1996) 1.22
Human fibroblast interferon. An improved purification. J Biol Chem (1981) 1.18
In vivo and in vitro synthesis of human rhinovirus type 2 ribonucleic acid. J Virol (1972) 1.18
Antiviral and cell growth inhibitory activities reside in the same glycoprotein of human fibroblast interferon. Nature (1976) 1.18
A cell surface alteration in mouse L cells induced by interferon. Biochem Biophys Res Commun (1977) 1.18
Orthopaedic intervention in early rheumatoid arthritis. Occurrence and predictive factors in an inception cohort of 1064 patients followed for 5 years. Rheumatology (Oxford) (2004) 1.16
Hepatitis C and substance use in a sample of homeless people in New York City. J Addict Dis (2001) 1.13
Proceedings: Aortic valve replacement using fresh unstented homografts. Thoraxchir Vask Chir (1973) 1.11
Flavodoxin: a flavoprotein with ferredoxin activity from Clostrium pasteurianum. Biochim Biophys Acta (1966) 1.08
Correlates of cocaine/crack use among inner-city incarcerated adolescents. Am J Drug Alcohol Abuse (1994) 1.00
Letter: Sudden death in infancy. Nature (1975) 0.98
A group motivational treatment for chemical dependency. J Subst Abuse Treat (1999) 0.97
Flavodoxin. Chemical and biological properties. J Biol Chem (1967) 0.97
Chronic nutmeg psychosis. J R Soc Med (1993) 0.97
Orthodeoxia: a new finding in interstitial fibrosis. Am Rev Respir Dis (1987) 0.94
A latent variable analysis of coexisting emotional deficits in substance abusers: alexithymia, hostility, and PTSD. Addict Behav (2000) 0.93
Patients' perspective on the process of change in substance abuse treatment. J Subst Abuse Treat (1996) 0.93
Oral anticoagulation in atrial fibrillation: A pan-European patient survey. Eur J Intern Med (2007) 0.93
The use of "fresh" unstented homograft valves for replacement of the aortic valve: analysis of 6 1/2 years experience. Circulation (1977) 0.93
Mitochondria-associated ribonucleic acid of the HeLa cell. Effect of ethidium bromide on the synthesis of ribosomal and 4S ribonucleic acid. Biochemistry (1969) 0.91
Coronary angiography Review of 1500 consecutive cases. Br Heart J (1976) 0.90
The association between cocaine use and HIV/STDs among soup kitchen attendees in New York City. J Acquir Immune Defic Syndr (2000) 0.89
Fatal hypercalcaemia complicating carcinoma of breast, resistant to cortisone and phosphate administration. Br Med J (1967) 0.88
Male partners of substance-abusing women in treatment: an exploratory study. Am J Drug Alcohol Abuse (1999) 0.87
Interferon-Sepharose: induction of the antiviral state. Biochem Biophys Res Commun (1974) 0.87
Human interferon-beta: effects of deglycosylation. J Interferon Res (1982) 0.87
Preparation of 125iodine-labelled human fibroblast interferon. J Gen Virol (1978) 0.85
Bromocriptine for cocaine dependence. A controlled clinical trial. Am J Addict (1997) 0.85
Cessation of drug use: impact of time in treatment. J Psychoactive Drugs (2001) 0.85
ARRIVE: an AIDS education/relapse prevention model for high-risk parolees. Int J Addict (1994) 0.84
X-ray studies on phospholipid bilayers. II. Polymorphic forms of dipalmitoyl phosphatidylethanolamine. Z Naturforsch C (1983) 0.84
Enhanced treatment outcomes for cocaine-using methadone patients. Drug Alcohol Depend (1999) 0.84
A 15-kD interferon-induced protein and its 17-kD precursor: expression in Escherichia coli, purification, and characterization. J Interferon Res (1989) 0.83
Interferon-beta enhances the synthesis of a 20,000-dalton membrane protein: a correlation with the cessation of cell growth. J Interferon Res (1985) 0.83
Comparison of doxorubicin with cycloleucine in the treatment of sarcomas. Cancer Treat Rep (1981) 0.83
Managed care: recovery enhancer or inhibitor? Psychiatr Serv (2001) 0.83
Vascular access for cancer chemotherapy. JAMA (1977) 0.83
Aortic valve replacement using fresh unstented homografts. Br Heart J (1973) 0.81
Impact of gavage dosing procedure and gastric content on adverse respiratory effects and mortality in rat toxicity studies. J Appl Toxicol (2010) 0.81
Interferons and the regulation of oncogenes. Interferon (1986) 0.79
Production and characterization of recombinant mouse brain-derived neurotrophic factor and rat neurotrophin-3 expressed in insect cells. J Neurochem (1994) 0.78
Transurethral resection of the prostate: still the gold standard. Aust N Z J Surg (1997) 0.78
Proceedings: Coronary angiography using Judkins method. Br Heart J (1974) 0.78
Antibodies to synthetic peptides of human interferon-beta. Use in biosynthetic studies. J Biol Chem (1984) 0.77
Proceedings: Late results of mitral valve replacement using "fresh" unstented aortic homografts. Thoraxchir Vask Chir (1973) 0.77
Daily cocaine use patterns: effects of contextual and psychological variables. J Addict Dis (1996) 0.77
Interferon: effect on the saturation density to which mouse cells will grow in vitro. J Cell Biol (1973) 0.76
Turnover of HeLa ribosomal RNA. The characterization of a class of RNA in HeLa cytoplasm derived from 28S RNA. J Cell Biol (1971) 0.75
HIV transmission in simulated conditions of sharing hypodermic equipment. J Acquir Immune Defic Syndr (1992) 0.75
Transfer RNA: A comparison by gel electrophoresis of the tRNA in HeLa cytoplasm, HeLa mitochondrial fraction, and E. coli. Proc Natl Acad Sci U S A (1969) 0.75
Variations in methadone treatment practices. JAMA (1992) 0.75
Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271). Cancer Chemother Rep (1975) 0.75
Stimulation of Pyrophosphatase Activity in Clostridium pasteurianum by Reductants. J Bacteriol (1965) 0.75
Vascular access for cancer chemotherapy. Cancer (1979) 0.75
Left ventricular aneurysm: current appraisal. Br Heart J (1973) 0.75
Late results of direct myocardial revascularisation. Thoraxchir Vask Chir (1974) 0.75
Ribosomal RNA associated with HeLa mitochondria. Biochim Biophys Acta (1969) 0.75
Patents and literature. Appl Biochem Biotechnol (1981) 0.75
Effects of salicylamide and protein restriction on the skeletal development of the rat fetus. Teratology (1978) 0.75
Radioisotopes labeling of interferons. Tex Rep Biol Med (1983) 0.75
Video techniques with chemically-dependent patients. Subst Use Misuse (1996) 0.75
Considerations in our search for interferons for clinical use. Adv Exp Med Biol (1978) 0.75
Interferon-sepharose: priming of L cells for induction of interferon by MM virus. J Gen Virol (1974) 0.75
Characterization of radioactive human fibroblast-derived beta interferon synthesized in vivo. J Interferon Res (1981) 0.75
A growth inhibitory protein secreted by human diploid fibroblasts. Partial purification and characterization. J Biol Chem (1987) 0.75
In vivo radiolabeling of human IFN-beta. Methods Enzymol (1986) 0.75
[Counseling of unmarried, teenage expectant mothers]. Taehan Kanho (1965) 0.75
Purification of human fibroblast interferon prepared in the absence of serum. Methods Enzymol (1981) 0.75
E. coli transfer RNA: fractionation by electrophoresis on polyacrylamide gel. Prep Biochem (1971) 0.75
Effect of salicylamide on the placental transfer and fetal tissue distribution of sodium-35S-sulfate in the rat. J Nutr (1978) 0.75
Proceedings: A new development in ultrasound, using a multi-transducer technique. Br Heart J (1974) 0.75